Unknown

Dataset Information

0

Novel immunotherapeutic approaches to the treatment of urothelial carcinoma.


ABSTRACT: Immunotherapy has long played a role in urothelial cancers with the use of bacille Calmette Guérin (BCG) being a mainstay in the treatment of nonmuscle invasive bladder cancer. Novel therapeutic approaches have not significantly impacted mortality in this population and so a renaissance in immunotherapy has resulted. This includes recombinant BCG, oncolytic viruses, monoclonal antibodies, vaccines, and adoptive T-cell therapy. Herein, we provide a review of the current state of the art and future therapies regarding immunotherapeutic strategies for urothelial carcinoma.

SUBMITTER: Muthigi A 

PROVIDER: S-EPMC4872187 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Novel immunotherapeutic approaches to the treatment of urothelial carcinoma.

Muthigi Akhil A   George Arvin K AK   Brancato Sam J SJ   Agarwal Piyush K PK  

Therapeutic advances in urology 20160209 3


Immunotherapy has long played a role in urothelial cancers with the use of bacille Calmette Guérin (BCG) being a mainstay in the treatment of nonmuscle invasive bladder cancer. Novel therapeutic approaches have not significantly impacted mortality in this population and so a renaissance in immunotherapy has resulted. This includes recombinant BCG, oncolytic viruses, monoclonal antibodies, vaccines, and adoptive T-cell therapy. Herein, we provide a review of the current state of the art and futur  ...[more]

Similar Datasets

| S-EPMC3565214 | biostudies-literature
| S-EPMC3760468 | biostudies-literature
| S-EPMC5082377 | biostudies-literature
| S-EPMC5464921 | biostudies-literature
| S-EPMC5730869 | biostudies-literature
| S-EPMC7352972 | biostudies-literature
| S-EPMC4372273 | biostudies-literature
| S-EPMC4713888 | biostudies-literature
| S-EPMC8366114 | biostudies-literature